EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Keymed Biosciences's enterprise value is HK$8,410.8 Mil.
Keymed Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$387.3 Mil. Therefore, Keymed Biosciences's EV-to-Revenue for today is 21.72.
The historical rank and industry rank for Keymed Biosciences's EV-to-Revenue or its related term are showing as below:
HKSE:02162'
s EV-to-Revenue Range Over the Past 10 Years
Min: -9.03 Med: 21.71 Max: 150.12
Current: 23.29
During the past 5 years, the highest EV-to-Revenue of Keymed Biosciences was 150.12. The lowest was -9.03. And the median was 21.71.
HKSE:02162's EV-to-Revenue is ranked worse than 69.17% of 1038
companies
in the Biotechnology industry
Industry Median: 7.97
vs HKSE:02162: 23.29
The historical data trend for Keymed Biosciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Keymed Biosciences's EV-to-Revenue
For the Biotechnology subindustry, Keymed Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Keymed Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Keymed Biosciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Keymed Biosciences's EV-to-Revenue falls into.
Keymed Biosciences's current Enterprise Value is HK$8,410.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Keymed Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$387.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Keymed Biosciences's share price for today is HK$39.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.46.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Keymed Biosciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Keymed Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Keymed Biosciences (HKSE:02162) Business Description
Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of innovative biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it operates in Hong Kong & Mainland China, out of which the majority is from Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02162 has been successfully added to your 